Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FraxPro laser plus topical desonide vs FraxPro laser plus placebo for axillary hyperpigmentation
IRCT20240621062202N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Hyperpigmentation comparing FraxPro laser + topical desonide with FraxPro laser + topical placebo (2 arms). Started Dec 2024; status: completed.
02
Drugs
desonide
03
Conditions
Hyperpigmentation
Beyond the preview
Go deeper on IRCT20240621062202N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240621062202N1.